Percutaneous penetration enhancement of propranolol hydrochloride from HPMC-Based hydroethanolic gels containing terpenes

Farmacia

Volumn 62, Issue 5, 2014, Pages 992-1008

  Vlaia, Lavinia ^a   Olariu, Ioana ^a   Coneac, Georgeta ^a   Vlaia, VicenţIu ^a   Popoiu, CăLin ^a   Corina, StăNciulescu ^a   Muţ, Ana Maria ^a   Szabadai, Zoltan ^a   Lupuleasa, Dumitru ^b  

^a VICTOR BABES UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^b CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

Hydroethanolic gel; Percutaneous penetration; Propranolol hydrochloride (PRHCl); Terpenes

Indexed keywords

BISABOLOL; CAMPHOR; CINEOLE; HYDROXYPROPYLMETHYLCELLULOSE; MENTHOL; PROPRANOLOL; TERPENE DERIVATIVE; THYMOL;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIFFUSION COEFFICIENT; DRUG RELEASE; EXCIPIENT COMPATIBILITY; FIRST ORDER KINETICS; FLOW KINETICS; HIGUCHI MODEL; KORSMEYER PEPAS MODEL; LAG TIME; MEMBRANE PERMEABILITY; MEMBRANE TRANSPORT; NONHUMAN; PHYSICAL PARAMETERS; SKIN PENETRATION; STRATUM CORNEUM; ULTRAVIOLET SPECTROPHOTOMETRY; ZERO ORDER MODEL;

EID: 84908550482     PISSN: 00148237     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Srikanth M.V., Sunil S.A., Sreenivasa Rao N., Janaki Ram B., Ramana Murthy K.V., Thermal sintering: a novel technique used in the design of gastroretentive floating tablets of propranolol HCl and its statistical optimization using box-behnken design. Farmacia, 2012; 60(3): 411-435.
2. Amnuaikit C., Ikeuchi I., Ogawara K., Higaki K., Kimura T., Skin permeation of propranolol from polymeric film containing terpene enhancers for transdermal use. Int. J. Pharm., 2005; 289: 167-178.
3. Blanco M.D., Olmo R.M., Teijón J.M., Hydrogels In Encyclopedia of Pharmaceutical Technology, vol. 3. Informa Healthcare, New York, 2007; 2021-2039.
4. Bonifazi E., Mazzotta F., Colonna V., De Leo E., Milano A., Topical propranolol in the superficial infantile hemangiomas of the skin. Eur. J. Pediat. Dermatol., 2010; 20: 247-251.
5. Cornwell P.A., Barry B.W., Bouwstra J.A., Gooris G.S., Modes of action of terpene penetration enhancers in human skin: differential scanning calorimetry, smallangle X-ray diffraction and enhancer uptake studies. Int. J. Pharm., 1996; 127: 9-26.
6. Costa-Balogh F.O., Sparr E., Sousa J.J.S., Pais A.A.C.C., Drug release and skin permeation from lipid liquid crystalline phases. Progr. Colloid. Polym. Sci., 2008; 135: 119-129.
7. Cui Y., Li L., Zhang L., Li J., Gu J., Gong H., Guo P., Tong W., Enhancement and Mechanism of Transdermal Absorption of Terpene-Induced Propranolol Hydrochloride. Arch. Pharm. Res., 2011; 34(9): 1477-1485.
8. Narasimha S. Managoli, Raghavendra V, Kulkarni, Ramarao N, Muchandi I.S., Crosslinked chitosan hydrogel matrix tablets for controlled release of gabapentin. Farmacia, 2012; 60(2): 272-286.
9. Kobayashi I., Hosaka K., Ueno T., Maruo H., Kamiyama M., Konno C., Gemba M., Relationship between amount of beta-blockers permeating through the stratum corneum and skin irritation after application of beta-blocker adhesive patches to guinea pig skin. Biol. Pharm. Bull., 1997; 20(4): 421-427.
10. Krishna R., Pandit J.K., Transdermal delivery of propranolol. Drug. Dev. Ind. Pharm., 1994; 20: 2459-2465.
11. Kunta J.R., Goskonda V.R., Brotherton H.O., Khan M.A., Reddy I.K., Effect of Menthol and Related terpenes on the Percutaneous Absorption of Propranolol across excised Hairless Mouse Skin. J. Pharm. Sci., 1997; 86(12): 1369-1373.
12. Kunzi-Rapp K. Topical propranolol therapy for infantile hemangiomas. Pediatr. Dermatol., 2012; 29(2): 154-159.
13. Lane M.E., Skin penetration enhancers. Int. J. Pharm. Sci., 2013; 447: 12-21.
14. Léauté-Labrèze C., Dumas de la Roque E, Hubiche T, Boralevi F., Thambo J.B., Taïeb A. Propranolol for severe hemangiomas of infancy. N. Engl. J. Med., 2008; 358(24): 2649-2651.
15. Megrab N.A, Williams A.C., Barry B.W., Oestradiol permeation across human skin, silastic and snake skin membranes: the effects of ethanol/water cosolvent system. Int. J. Pharm., 1995; 116: 101-112.
16. Mishra D., Garg M., Dubey V., Jain S., Jain N.K., Elastic liposomes mediated transdermal delivery of an anti-hypertensive agent: propranolol hydrochloride. J. Pharm. Sci., 2007; 96: 145-155.
17. Namdeo A., Jain N.K., Liquid crystalline pharmacogel based enhanced transdermal delivery of propranolol hydrochloride. J. Controll. Release, 2002; 82: 223-236.
18. Peppas N.A., Bures P., Leobandung W., Ichikawa I., Hydrogels in pharmaceutical formulations. Eur. J. Pharm. and Biopharm.. 2000; 50: 27-46.
19. Riddell J.G., Harron D.W.G., Shanks R.G., Clinical pharmacokinetics of P-drenoceptor antagonists. An update. Clin. Pharmacokinet., 1987; 12: 305-320.
20. Sánchez-Carpintero I., Ruiz-Rodriguez R., López-Gutiérrez J.C., Propranolol in the treatment of infantile hemangioma: clinical effectiveness, risks, and recommendations. Actas Dermosifiliogr., 2011; 102(10): 766-779.
21. Sapra B., Jain S., Tiwary A.K., Percutaneous Permeation Enhancement by Terpenes: Mechanistic View. A.A.P.S.J., 2008; 10(1): 120-132.
22. Silber B.M., Holford N.H.G., Riegelman S., Dose-dependent elimination of propranolol and its major metabolites in humans. J. Pharm. Sci., 1983; 72(12): 1442-1446.
23. Szabadai Z., Vlaia V., Ţăranu I., Ţăranu B.O., Vlaia L., Popa I., Multivariate Data Processing in Spectrophotometric Analysis of Complex Chemical Systems in Uddin, J. (editor) Macro to Nano Spectroscopy. InTech Publ.. Rijeka, Croaţia, 2012; 291-316.
24. Trommer H., Neubert R.H.H., Overcoming the Stratum Corneum: The Modulation of Skin Penetration. Skin Pharmacol. Physiol., 2006; 19: 106-121.
25. Vaddi H.K., Ho P.C., Chan Y.W., Chan S.Y., Terpenes in ethanol: haloperidol permeation and partition through human skin and stratum corneum changes. J..Control. Release., 2002; 81: 121-133.
26. Williams A., Barry B., Penetration enhancers. Adv. Drug Deliv. Rev., 2004; 53: 603-618.
27. Wodlinger A.M., Cardiovascular Drugs in Troy, D.B., Beringer, P. (eds.). Remington: The Science and Practice of Pharmacy. Lippincott Williams & Wilkins, Philadelphia, 2006; 1355.
28. Zvulunov A., McCuaig C., Frieden I.J., Mancini A.J., Puttgen K.B., Dohil M., Fischer G., Powell J., Cohen B., Ben Amitai D., Oral propranolol therapy for infantile hemangiomas beyond the proliferation phase: a multicenter retrospective study. Pediatr. Dermatol., 2011; 28(2): 94-98.
29. Zvulunov A., McCuaig C., Frieden I.J., Mancini A.J., Puttgen K.B., Dohil M., Fischer G., Powell J., Cohen B., Ben Amitai D. METHOCEL Cellulose Ethers Technical Handbook. Dow Chemical Company. 2002; 12-13.